PFIZER REPORTS SECOND-QUARTER 2021 RESULTS
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/4/2026
- Equities close higher as softer jobs data quiets rate-hike expectations
- U.S. economy adds fewer jobs than expected as unemployment rate ticks higher
- Nvidia returns as Morgan Stanley’s Top Pick on attractive valuation
- Citi says rate volatility without Fed repricing is concerning
- U.S. credit-reporting stocks fall as FHFA weighs two-bureau mortgage rule
- Equities close higher as softer jobs data quiets rate-hike expectations
- Cantor Fitzgerald on Rivian (RIVN): 'pre-announced that it delivered 19,248 vehicles in 3Q26, above our estimate'
- DISH DBS emerges from bankruptcy, cuts debt by $4.35 billion
- Tanker struck by projectile in Strait of Hormuz
- AppLovin shares fall after court denies request against Unity
Pfizer (PFE) Tops Q2 EPS by 11c, Updates FY Guidance
July 28, 2021 6:46 AM EDTPfizer (NYSE: PFE) reported Q2 EPS of $1.07, $0.11 better than the analyst estimate of $0.96. Revenue for the quarter came in at $19 billion versus the consensus estimate of $18.45 billion.
GUIDANCE:
Pfizer sees FY2021 EPS of $3.95-$4.05, versus the consensus of $3.70. Pfizer sees... More
